Profound Medical Corp.

NasdaqCM:PROF Stock Report

Market Cap: US$217.2m

Profound Medical Past Earnings Performance

Past criteria checks 0/6

Profound Medical's earnings have been declining at an average annual rate of -11.5%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 9.1% per year.

Key information

-11.5%

Earnings growth rate

0.2%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate9.1%
Return on equity-101.1%
Net Margin-349.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Profound Medical Q2 GAAP EPS beats, revenue in-line

Aug 04

Profound Medical Lacks Conviction To Overthrow Macro Headwinds

Jul 10

Revenue & Expenses Breakdown

How Profound Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:PROF Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 249-312216
30 Jun 248-282016
31 Mar 247-281914
31 Dec 237-291914
30 Sep 236-291713
30 Jun 237-291715
31 Mar 237-271815
31 Dec 227-291815
30 Sep 226-292016
30 Jun 227-302016
31 Mar 228-311915
31 Dec 217-311815
30 Sep 219-281613
30 Jun 218-281413
31 Mar 217-261311
31 Dec 207-221210
30 Sep 207-181210
30 Jun 205-17119
31 Mar 204-161010
31 Dec 194-1589
30 Sep 193-1579
30 Jun 193-1479
31 Mar 193-1478
31 Dec 182-1588
30 Sep 182-1688
30 Jun 183-1678
31 Mar 184-1578
31 Dec 174-1578
30 Sep 172-1588
30 Jun 171-1467
31 Mar 170-1257
31 Dec 160-1247
30 Sep 160-1146
30 Jun 160-1046
31 Mar 160-1455
31 Dec 150-1254
30 Sep 150-1253
30 Jun 150-1243
31 Mar 150-822
31 Dec 140-722

Quality Earnings: PROF is currently unprofitable.

Growing Profit Margin: PROF is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PROF is unprofitable, and losses have increased over the past 5 years at a rate of 11.5% per year.

Accelerating Growth: Unable to compare PROF's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PROF is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.9%).


Return on Equity

High ROE: PROF has a negative Return on Equity (-101.05%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 02:55
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Profound Medical Corp. is covered by 15 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David KideckelBeacon Securities Limited
Jason MillsCanaccord Genuity
Prakash GowdCIBC Capital Markets